Data / Form D filings / OMEROS CORP
OMEROS CORP: Form D filings
OMEROS CORP, a biotechnology company in Seattle, WA, filed 2 Form D notices with the SEC in 2010. The latest, on October 27, 2010, reports an offering of $12 million with nothing sold yet to 1 investor.
Find out what OMEROS CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1420 5TH AVE, SUITE 2600, Seattle, WA, 98101
- Phone
- (206) 676-5000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1285819
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2010 | New notice | $11,999,970 | $0 | $11,999,970 | 1 | Yet to occur | sec.gov |
| Aug 13, 2010 | New notice | $40,000,000 | $0 | $40,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| LEROY E. HOOD | Director | |
| DANIEL K. SPIEGELMAN | Director | |
| THOMAS J. CABLE | Director | |
| GREGORY A. DEMOPULOS | Executive Officer, Director | |
| RAY S. ASPIRI | Director | |
| PETER A. DEMOPULOS | Director | |
| JEAN-PHILIPPE K. TRIPET | Director | |
| MARCIA S. KELBON | Executive Officer |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Oct 25, 2010 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OMEROS CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.